Home › Funds › Caligan Partners LP › CLRB

Caligan Partners LP position in CLRB

CELLECTAR BIOSCIENCES INC · Health Care

Caligan Partners LP reported holding 469,998 shares of CLRB (CELLECTAR BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$865K, representing 0.05% of its reported portfolio and ranking #25 among its reported holdings. Caligan Partners LP has disclosed CLRB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)470.00K sh
Reported value held$864.80K
Portfolio Weight0.05%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's CLRB position evolved

Caligan Partners LP first disclosed a stake in CLRB in Q2 2026 at 469,998 shares (US$1.3M). Across 2 filings, Caligan Partners LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 469,998 shares valued at US$865K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 470.00K $1.31M New
Q3 2026 470.00K $864.80K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLRB and 13F data

CLRB (CELLECTAR BIOSCIENCES INC) is a Health Care company. 22 other funds we track also report a position in CLRB — the largest reported positions include Empery Asset Management, LP (US$1.8M), Stonepine Capital Management, LLC (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLRB

All CLRB fund holders →

FAQ

How long has Caligan Partners LP held CLRB?

Caligan Partners LP has disclosed CLRB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Caligan Partners LP's current position in CLRB?

As of Q3 2026, Caligan Partners LP holds 470.00K shares of CLRB (CELLECTAR BIOSCIENCES INC), valued at $864.80K, representing 0.05% of its reported portfolio and ranking #25.

Has Caligan Partners LP been buying or selling CLRB?

In the latest 13F filing (Q3 2026), Caligan Partners LP held unchanged its position in CLRB.

Which other funds hold CLRB?

Other major institutional holders of CLRB include Empery Asset Management, LP, Stonepine Capital Management, LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.